Stonebrook Private’s iShares iBonds Dec 2031 Term Corporate ETF IBDW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.42M Buy
115,789
+4,930
+4% +$104K 0.52% 41
2025
Q4
$2.34M Buy
110,859
+3,705
+3% +$78.5K 0.49% 40
2025
Q3
$2.27M Buy
107,154
+1,320
+1% +$27.8K 0.49% 53
2025
Q2
$2.23M Buy
105,834
+2,624
+3% +$54.2K 0.52% 50
2025
Q1
$2.14M Buy
103,210
+6,304
+7% +$129K 0.56% 52
2024
Q4
$1.97M Buy
96,906
+8,630
+10% +$178K 0.52% 52
2024
Q3
$1.87M Buy
88,276
+26,465
+43% +$552K 0.5% 59
2024
Q2
$1.25M Buy
61,811
+14,592
+31% +$294K 0.36% 70
2024
Q1
$968K Buy
47,219
+19,536
+71% +$399K 0.28% 72
2023
Q4
$575K Buy
+27,683
New +$545K 0.19% 101

Other funds holding IBDW

Stonebrook Private's IBDW Position: Q1 2026 in Review

Stonebrook Private increased its iShares iBonds Dec 2031 Term Corporate ETF (IBDW) stake by 4.4% in Q1 2026, buying an estimated $104K and bringing the position to 115,789 shares worth $2.42M. The position accounts for 0.52% of the portfolio, ranked #41.

Stonebrook Private first reported a position in IBDW in Q4 2023 and has held it in 10 quarters since. 288 funds tracked by Wall St. Rank hold IBDW as of Q1 2026.

  • Stonebrook Private held 115,789 shares of iShares iBonds Dec 2031 Term Corporate ETF worth $2.42M as of Q1 2026.
  • Stonebrook Private bought 4,930 iShares iBonds Dec 2031 Term Corporate ETF shares in Q1 2026, an estimated $104K.
  • iShares iBonds Dec 2031 Term Corporate ETF made up 0.52% of Stonebrook Private's portfolio in Q1 2026, its #41 holding.
  • Stonebrook Private first reported a position in iShares iBonds Dec 2031 Term Corporate ETF in Q4 2023 and has held it in 10 quarters since.
  • 288 funds tracked by Wall St. Rank held iShares iBonds Dec 2031 Term Corporate ETF as of Q1 2026.

Based on Stonebrook Private's 13F filing for Q1 2026, filed 11 May 2026.